Sellas stock surges on ‘conversation-changing’ Phase III cancer vaccine victory
GlobalData analyst Israel Stern says that GPS has overcome the challenge of getting a blood cancer vaccine to demonstrate a survival benefit.
GlobalData analyst Israel Stern says that GPS has overcome the challenge of getting a blood cancer vaccine to demonstrate a survival benefit.